RenovoRx Inc
Biotechnology
Healthcare
RNXT
31.40 M shares
NASDAQ US
traded
19 Sep 2025
listed
no
open
1.27
52 week high
1.75
high
1.45
52 week low
0.00
low
1.26
growth
9.02 %
previous Close
1.32
P/E ratio
market cap
49.74 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
1228.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top